"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

In this interview, Cerba Research explains how its teams were able to assess clinical response in multiple myeloma (MM) patients that were receiving monoclonal antibodies treatment. In multiple ...

Author: Guido Lancman, MD, a clinical associate at the Princess Margaret Cancer Centre of the University Health Network and an adjunct assistant professor at the University of Toronto Background: ...

Please provide your email address to receive an email when new articles are posted on . IV immunoglobulin supplementation reduced the risk for developing severe infections among those receiving ...

Multiple myeloma is a type of blood cancer that starts in your bone marrow. This is the soft, spongy tissue inside your bones that makes most of your blood cells. It includes plasma cells, which help ...

Multiple myeloma starts with genetic changes in plasma cells, which are not inherited but occur spontaneously. The condition progresses from monoclonal gammopathy of undetermined significance (MGUS) ...